Novoron Bioscience
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
About Novoron Bioscience
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).
Company Facts
- Headquarters
- San Diego
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- seed
- Total Funding
- $18,665,350
- Last Funding Type
- grant
- Last Funding Date
- 2026-01-06
- Website
- novoron.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Neuroscience, Pharmaceutical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/novoron-bioscience-114062 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.